{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-107741","form_type":"8-K","ticker":"ELUT","cik":"0001708527","company_name":"ELUTIA INC.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.224968+00:00","generated_at":"2026-05-16T23:49:01.426520+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Elutia Q3 revenue $3.3M, closes $88M BioEnvelope sale to Boston Scientific, pays off debt","bullets":["Net sales $3.3M (down from $3.7M YoY); loss from operations $5.2M vs $9.2M loss a year ago.","Closed sale of BioEnvelope business to Boston Scientific for $88M; used $27.8M to repay SWK loan facility in full.","Advancing NXT-41x for plastic/reconstructive surgery; FDA clearance of base matrix expected 2H26, drug-eluting version 1H27.","Cash balance $4.7M at Sep 30, 2025; received $80.3M net proceeds on Oct 1, 2025 after closing and escrow.","Settled 7 additional FiberCel cases, leaving only 6 unresolved; Guido J. Neels appointed to Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-107741","json":"https://secwatch.observer/filing/0001104659-25-107741.json","markdown":"https://secwatch.observer/filing/0001104659-25-107741.md","text":"https://secwatch.observer/filing/0001104659-25-107741.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708527/000110465925107741/0001104659-25-107741-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708527/000110465925107741/tm2530506d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:49:01.426520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}